Ascentage Pharma Group International
Organization details
- Legal name
- Ascentage Pharma Group International
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- Suzhou , Jiangsu
- Headquarters country
- China
- Fiscal year end
- December
- Ticker symbol
- AAPG
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002023311
Board of directors
-
Changqing Ye · DirectorSince 2026
-
Dajun Yang · Director · Chairman and CEOSince 2026
-
David Sidransky · DirectorSince 2026
-
Debra Yu · DirectorSince 2026
-
Marc E. Lippman · DirectorSince 2026
-
Marina Bozilenko · DirectorSince 2026
-
Ren Wei · DirectorSince 2026
-
Shaomeng Wang · DirectorSince 2026
-
Simon Dazhong Lu · DirectorSince 2026
Chief executives
Board connections
4 of this board's directors also sit on 6 other boards. 4 are in the same sector.
- via Changqing Ye
-
Champions Oncology Inc. Same sectorvia David Sidransky
-
Eocene Ltd. Same sectorvia David Sidransky
-
MeiraGTx Holdings plc Same sectorvia Debra Yu
- via Changqing Ye
-
Talphera Inc. Same sectorvia Marina Bozilenko
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 21, 2026 | Zhai Yifan Officer (Chief Medical Officer) | Option exercise | +92,746 | — | — |
| May 21, 2026 | Dajun Yang Director, Officer (Chairman and CEO) | Option exercise | +95,575 | — | — |
| May 21, 2026 | Zhai Yifan Officer (Chief Medical Officer) | Option exercise | +95,575 | — | — |
| May 21, 2026 | Dajun Yang Director, Officer (Chairman and CEO) | Option exercise | +92,746 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Ascentage Pharma Group International
Who is the CEO of Ascentage Pharma Group International?
Dajun Yang has been Ascentage Pharma Group International's Chairman and CEO since March 2026.
How many directors are on Ascentage Pharma Group International's board?
Ascentage Pharma Group International's board has 9 directors: Changqing Ye, Dajun Yang, David Sidransky, Debra Yu, Marc E. Lippman, Marina Bozilenko, Ren Wei, Shaomeng Wang and Simon Dazhong Lu.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="ascentage-pharma-group-international"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.